secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001104659-24-049400
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path raises additional $1.1M ATM capacity after completing initial $2M sale
-------------------------------------------------------------------------------

- Sold 436,511 shares for ~$2.0M gross proceeds under prior ATM; offering terminated April 19, 2024.
- New ATM prospectus supplement filed to sell up to additional $1,107,871 of common stock.
- Proceeds from the expanded ATM will be used for working capital and general corporate purposes.
- H.C. Wainwright & Co. acts as sales agent; no minimum offering and no obligation to sell.
- Shares offered under existing shelf registration statement (333-265282) declared effective June 14, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000110465924049400/0001104659-24-049400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000110465924049400/tm2412196d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-049400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer